Profile
International Journal of Diabetes & Clinical Diagnosis Volume 2 (2015), Article ID 2:IJDCD-113, 6 pages
http://dx.doi.org/10.15344/2394-1499/2015/113
Research Article
Measuring Second Phase of Insulin Secretion by Components of Metabolic Syndrome

Yi-Tien Lin1, Chung-Ze Wu2, Wei-Cheng Lian3, Chun-Hsien Hsu4, Chang-Hsun Hsieh5, Dee Pei6, Yen-Lin Chen7 and Jiunn-Diann Lin2*

1Graduate Institute of Business Administration, Fu Jen Catholic University, Taipei, Taiwan
2Division of Endocrinology, Department of Internal Medicine, Shuang-Ho Hospital, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
3Division of Endocrinology and Metabolism, Department of Internal of Medicine, Buddhist Dalin Tzu Chi General Hospital and School of Medicine, Tzu Chi University, Taiwan
4Department of Family Medicine, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan
5Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical School
6Department of Internal Medicine, Cardinal Tien Hospital, Medical School, Catholic Fu Jen University, New Taipei City, Taiwan
7Department of Pathology, Cardinal Tien Hospital, School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan
Dr. Jiunn-Diann Lin, Department of Internal Medicine, Shuang Ho Hospital, No.291, Zhongzheng Rd., Zhonghe District, New Taipei City, 23561, Taiwan, Tel: +886-2-22490088; E-mail: jdlin1971@yahoo.com.tw
28 November 2015; 29 December 2015; 31 December 2015
Lin YT, Wu CZ, Lian WC, Hsu CH, Hsieh CH, et al. (2015) Measuring Second Phase of Insulin Secretion by Components of Metabolic Syndrome. Int J Diabetes Clin Diagn 2: 113. doi: http://dx.doi.org/10.15344/2394-1499/2015/113

Abstract

Both decreased insulin sensitivity, and impaired insulin secretion are 2 major pathophyisologies for type 2 diabetes (T2DM). There are two phases of ISEC-the first (1st ISEC) and second phase (2nd ISEC). In this study, we tried to build an equation to predict 2nd ISEC.

Totally, 82 subjects, including 15 with normal fasting glucose, 26 with pre-diabetes and 41 with T2DM were enrolled. They received a modified low dose graded glucose infusion (M-LDGGI). The M-LDGGI is a simplified version of Polonsky’s method. The results were interpreted as the slope of the changes of plasma insulin against the glucose levels. The slopes of these curves were regarded as the 2nd ISEC.

If only metabolic syndrome (MetS) components were analyzed, the equation was built as the following: log (2nd ISEC) = -2.400- 0.088 • (fasting plasma glucose, FPG + 0.072 • (body mass index, BMI). After fasting plasma insulin (FPI) was added , the equation was shown as the following: log (2nd ISEC) = -2.316- 0.093˙FPG + 0.049 • BMI+ 0.434 • log(FPI). The second equation provided a greater accuracy to determine 2nd ISEC than first one in the external validation group (r2 = 0.545 vs r2 = 0.423).

Using MetS components, 2nd ISEC could be predicted with good accuracy. After adding FPI into the equation, the predictive power further increases. These equations could be widely used in daily practice and clinical settings.